NPI: 1720256647 · LOS ANGELES, CA 90022 · Community Health Clinic/Center · NPI assigned 02/13/2008
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 02/13/2008 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,806 | $1.39M |
| 2019 | 17,492 | $767K |
| 2020 | 13,295 | $528K |
| 2021 | 18,065 | $744K |
| 2022 | 14,650 | $535K |
| 2023 | 18,407 | $695K |
| 2024 | 15,400 | $523K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 14,015 | 12,926 | $745K |
| J3490 | Unclassified drugs | 19,901 | 16,766 | $673K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,190 | 4,852 | $658K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5,820 | 5,596 | $529K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 500 | 500 | $459K |
| S4993 | Contraceptive pills for birth control | 3,813 | 3,777 | $350K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,517 | 1,474 | $293K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 753 | 726 | $241K |
| 87806 | 8,949 | 7,026 | $220K | |
| 99201 | 1,751 | 1,605 | $218K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 726 | 667 | $149K |
| 11981 | 472 | 472 | $111K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 377 | 375 | $106K |
| A4267 | Contraceptive supply, condom, male, each | 15,195 | 14,790 | $90K |
| 81025 | 17,204 | 16,576 | $56K | |
| 11976 | 738 | 376 | $42K | |
| 99401 | 1,958 | 1,944 | $37K | |
| S5000 | Prescription drug, generic | 4,225 | 3,932 | $28K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 2,078 | 2,078 | $26K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 308 | 305 | $23K |
| 58300 | 255 | 125 | $22K | |
| 99000 | 5,341 | 5,324 | $19K | |
| 83986 | 5,331 | 4,359 | $14K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 3,442 | 3,355 | $13K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 31 | 31 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 579 | 559 | $10K |
| 86703 | 942 | 822 | $10K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 572 | 552 | $10K |
| 58301 | 186 | 97 | $5K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 1,141 | 1,117 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 206 | 204 | $3K |
| 81002 | 1,419 | 1,388 | $3K | |
| 86592 | 823 | 820 | $2K | |
| 99402 | 14 | 14 | $445.06 | |
| 82120 | 123 | 122 | $358.60 | |
| 87210 | 122 | 121 | $331.17 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 63 | 63 | $326.65 |
| 99070 | 35 | 25 | $0.03 |